{
    "2020-04-28": [
        [
            {
                "time": "2021-03-15",
                "original_text": "Even Johnson & Johnson Will Feel a Covid-19 Chill, Analyst Says",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Covid-19",
                        "Analyst"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-15",
                "original_text": "Dow erases 380-point gain Tuesday morning as tech-related and health-care shares drag stock market lower",
                "features": {
                    "keywords": [
                        "Dow",
                        "tech-related",
                        "health-care",
                        "stock market"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-15",
                "original_text": "Good News on Oxford Vaccine Is Bright Spot in Somber Covid-19 Landscape",
                "features": {
                    "keywords": [
                        "Oxford Vaccine",
                        "Covid-19"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-15",
                "original_text": "Drugmakers race to scale up vaccine capacity",
                "features": {
                    "keywords": [
                        "Drugmakers",
                        "vaccine",
                        "capacity"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}